Ordinary Adjustment | Solactive Future Pharmaceutical Europe Index | Effective Date 5th September 2025
Solactive Future Pharmaceutical Europe Index:
In the ordinary adjustment, the following composition will be implemented effective open 5th September 2025:
| ASTRAZENECA PLC |
| BAYER AG |
| GALDERMA GROUP AG |
| GENMAB A/S |
| GSK PLC |
| HALEON PLC |
| IPSEN SA |
| MERCK KGAA |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| RECORDATI SPA |
| ROCHE HOLDING AG |
| SANDOZ GROUP AG |
| SANOFI SA |
| UCB SA |